These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 30715799)

  • 1. DAN plays important compensatory roles in systemic-to-pulmonary shunt associated pulmonary arterial hypertension.
    Meng L; Liu X; Teng X; Yuan W; Duan L; Meng J; Li J; Zheng Z; Wei Y; Hu S
    Acta Physiol (Oxf); 2019 Jul; 226(3):e13263. PubMed ID: 30715799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretory clusterin is upregulated in rats with pulmonary arterial hypertension induced by systemic-to-pulmonary shunts and exerts important roles in pulmonary artery smooth muscle cells.
    Liu X; Meng L; Li J; Meng J; Teng X; Gu H; Hu S; Wei Y
    Acta Physiol (Oxf); 2015 Feb; 213(2):505-18. PubMed ID: 25069740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vital Roles of Gremlin-1 in Pulmonary Arterial Hypertension Induced by Systemic-to-Pulmonary Shunts.
    Meng L; Teng X; Liu Y; Yang C; Wang S; Yuan W; Meng J; Chi H; Duan L; Liu X
    J Am Heart Assoc; 2020 Aug; 9(15):e016586. PubMed ID: 32750294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin plays important roles in pulmonary arterial hypertension induced by systemic-to-pulmonary shunt.
    Meng L; Liu X; Teng X; Gu H; Yuan W; Meng J; Li J; Zheng Z; Wei Y; Hu S
    FASEB J; 2019 Jun; 33(6):7236-7251. PubMed ID: 30893567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nestin represents a potential marker of pulmonary vascular remodeling in pulmonary arterial hypertension associated with congenital heart disease.
    Zhou JJ; Li H; Qian YL; Quan RL; Chen XX; Li L; Li Y; Wang PH; Meng XM; Jing XL; He JG
    J Mol Cell Cardiol; 2020 Dec; 149():41-53. PubMed ID: 32950539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compensatory roles of Protein Related to DAN and Cerberus (PRDC) decrease in pulmonary arterial hypertension.
    He T; Zhang J; Qiao T; Zhang Z; Han H; Yang C; Chen Y; Ruan Y; Meng L
    Int J Biol Sci; 2022; 18(6):2372-2391. PubMed ID: 35414785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remodeling Matrix Synthesis in a Rat Model of Aortocaval Fistula and the Cyclic Stretch: Impaction in Pulmonary Arterial Hypertension-Congenital Heart Disease.
    Chang CJ; Huang CC; Chen PR; Lai YJ
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32630068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension.
    Gomez-Puerto MC; van Zuijen I; Huang CJ; Szulcek R; Pan X; van Dinther MA; Kurakula K; Wiesmeijer CC; Goumans MJ; Bogaard HJ; Morrell NW; Rana AA; Ten Dijke P
    J Pathol; 2019 Nov; 249(3):356-367. PubMed ID: 31257577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synemin promotes pulmonary artery smooth muscle cell phenotypic switch in shunt-induced pulmonary arterial hypertension.
    Zhou J
    ESC Heart Fail; 2022 Oct; 9(5):3221-3231. PubMed ID: 35769011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.
    Maruyama H; Dewachter C; Belhaj A; Rondelet B; Sakai S; Remmelink M; Vachiery JL; Naeije R; Dewachter L
    J Heart Lung Transplant; 2015 Mar; 34(3):468-78. PubMed ID: 25447587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgelin exacerbates pulmonary artery smooth muscle cell dysfunction in shunt-related pulmonary arterial hypertension.
    Zhou JJ; Yang J; Li L; Quan RL; Chen XX; Qian YL; Huang L; Wang PH; Li Y; Meng XM; Chen X; Gu Q; He JG
    ESC Heart Fail; 2022 Oct; 9(5):3407-3417. PubMed ID: 35841124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell RNA sequencing reveals that
    Du M; Jiang H; Liu H; Zhao X; Zhou Y; Zhou F; Piao C; Xu G; Ma F; Wang J; Perros F; Morrell NW; Gu H; Yang J
    Eur Respir J; 2022 Jul; 60(1):. PubMed ID: 34857612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin reduced pulmonary vascular remodelling by inhibiting cell proliferation via Akt/mTOR signalling pathway down-regulation in the carotid artery-jugular vein shunt pulmonary hypertension rat model.
    Ma X; Yao J; Yue Y; Du S; Qin H; Hou J; Wu Z
    Interact Cardiovasc Thorac Surg; 2017 Aug; 25(2):206-211. PubMed ID: 28475806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension.
    Van der Feen DE; Kurakula K; Tremblay E; Boucherat O; Bossers GPL; Szulcek R; Bourgeois A; Lampron MC; Habbout K; Martineau S; Paulin R; Kulikowski E; Jahagirdar R; Schalij I; Bogaard HJ; Bartelds B; Provencher S; Berger RMF; Bonnet S; Goumans MJ
    Am J Respir Crit Care Med; 2019 Oct; 200(7):910-920. PubMed ID: 31042405
    [No Abstract]   [Full Text] [Related]  

  • 15. MiR-23a regulates the proliferation and migration of human pulmonary artery smooth muscle cells (HPASMCs) through targeting BMPR2/Smad1 signaling.
    Zhang Y; Peng B; Han Y
    Biomed Pharmacother; 2018 Jul; 103():1279-1286. PubMed ID: 29864909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The BMP Receptor 2 in Pulmonary Arterial Hypertension: When and Where the Animal Model Matches the Patient.
    Happé C; Kurakula K; Sun XQ; da Silva Goncalves Bos D; Rol N; Guignabert C; Tu L; Schalij I; Wiesmeijer KC; Tura-Ceide O; Vonk Noordegraaf A; de Man FS; Bogaard HJ; Goumans MJ
    Cells; 2020 Jun; 9(6):. PubMed ID: 32521690
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroblastoma Suppressor of Tumorigenicity 1 Mediates Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension Related to Congenital Heart Disease.
    Wen B; Peng R; Kong P; Li Z; Liu Y; Ouyang W; Xie Y; Hu X; Wang Q; Pan X
    Am J Respir Cell Mol Biol; 2022 Dec; 67(6):666-679. PubMed ID: 36169661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
    Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
    Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMPR2-expressing bone marrow-derived endothelial-like progenitor cells alleviate pulmonary arterial hypertension in vivo.
    Harper RL; Maiolo S; Ward RJ; Seyfang J; Cockshell MP; Bonder CS; Reynolds PN
    Respirology; 2019 Nov; 24(11):1095-1103. PubMed ID: 30977250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
    Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.